<DOC>
	<DOC>NCT00862628</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy of rebamipide for NSAID-induced small-intestinal injuries.</brief_summary>
	<brief_title>The Effect of Rebamipide for Non-steroidal Anti-inflammatory Drugs (NSAID) - Induced Small-intestinal Injuries</brief_title>
	<detailed_description />
	<mesh_term>Anti-Inflammatory Agents, Non-Steroidal</mesh_term>
	<mesh_term>Rebamipide</mesh_term>
	<criteria>Written informed consent 20 to 85 years of age RA, OA, or low back pain No change of drugs before 3 months Under 5 mg of corticosteroid use CRP &lt; 1mg/dl Smallintestinal mucosal injuries more than one Hemoglobin level is below normal range Known or suspected smallbowel disease, including Crohn's disease and seronegative arthritis Prostaglandins, metronidazole or salazosulfapyridine Can not swallow Eith pacemaker After gastrointestinal operation Serious concomitant cardiovascular, endocrine, gastrointestinal(including symptoms of ileus), neurologic, psychiatric, renal, or respiratory disease. Taking rebamipide before one week Any other conditions that the investigator feels would interfere with data interpretation or create under risk.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>